Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Dow
Merck
Colorcon
AstraZeneca

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Panray Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for PANRAY, and what generic and branded alternatives to PANRAY drugs are available?

PANRAY has thirteen approved drugs.



Summary for Panray
US Patents:0
Tradenames:14
Ingredients:14
NDAs:13

Drugs and US Patents for Panray

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Panray PREDNISOLONE prednisolone TABLET;ORAL 080351-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Panray ISONIAZID isoniazid TABLET;ORAL 008428-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Panray AMINOPHYLLINE aminophylline TABLET;ORAL 084552-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Baxter
Boehringer Ingelheim
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.